
Antraquinonas e Derivados
As antraquinonas possuem uma estrutura baseada num núcleo benzênico fundido com um anel de quinona. Essa estrutura confere-lhes alta estabilidade e reatividade com uma variedade de biomoléculas. Os derivados das antraquinonas podem ser utilizados pelas suas propriedades biológicas, incluindo atividades antibacterianas, anti-inflamatórias e laxantes, além de possíveis aplicações na síntese de compostos farmacêuticos e na indústria química.
Na CymitQuimica, oferecemos antraquinonas e seus derivados com diversas aplicações em química orgânica e farmacêutica.
Foram encontrados 401 produtos de "Antraquinonas e Derivados"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Daunorubicinol Hydrochloride (Mixture of Diastereomers)
CAS:Produto ControladoFórmula:C27H31NO10·ClHCor e Forma:Red To Dark RedPeso molecular:566.00Rhein
CAS:<p>Impurity Diacerein Impurity C<br>Stability Hygroscopic<br>Applications Found in the free state and as glucoside in Rheum spp, Polygonaceae (rhubarb) and in Senna leaves.A potential antioxidant resource: endophytic fungi from medicinal plants . Diacerein Impurity C<br>References Wanitschke, Pharmacology, 20, Suppl. 1, 21 (1980), Raimondi, L., et al.: Pharmacol. Res. Commun., 14, 103 (1982), Franchi-Micheli, S., et al.: J. Pharm. Pharmacol., 35, 262 (1983),<br></p>Fórmula:C15H8O6Cor e Forma:NeatPeso molecular:284.22Desacetyl Bisacodyl b-D-Glucuronide
CAS:Produto Controlado<p>Stability Very Hygroscopic<br>Applications The glucuronide metabolite of Desacetyl Bisacodyl (D288670).<br>References Jauch, R., et al.: Arzneim.-Forsch., 27, 1045 (1977), Bradshaw, K., et al.: J. Pharm. Biomed. Anal., 13, 1355 (1995), Kudo,K., et al.: J. Anal. Toxocol., 22, 274 (1998),<br></p>Fórmula:C24H23NO8Cor e Forma:White To Off-WhitePeso molecular:453.444-Demethyl Daunomycinone
CAS:<p>Applications A metabolite Daunorubicin in liver microsomes.<br>References Ogawa, Y., et al.: J. Antibiotics, 37, 44 (1984), Schwartz, H.S., et al.: Cancer Res., 44, 2480 (1984), Burke, T.G., et al.: Biochemistry, 24, 1768 (1985),<br></p>Fórmula:C20H16O8Cor e Forma:RedPeso molecular:384.34Desacetyl Bisacodyl
CAS:<p>Impurity Bisacodyl USP Related Compound C<br>Applications Desacetyl Bisacodyl is an impurtiy in the preparation of Bisacodyl (B400800), cathartic.<br>References Schmidt, et al.: Arzneim.-Forsch., 3, 19 (1953), Wald, A., et al.: J. Clin. Gastroenterol., 36, 386 (2003); Metwally, F. et al.: J. AOAC. Int., 90, 113 (2007);<br></p>Fórmula:C20H17NO3Cor e Forma:WhitePeso molecular:319.35Sennoside A
CAS:Produto ControladoFórmula:C42H38O20Cor e Forma:Light Yellow To Dark YellowPeso molecular:862.74Deacetyl Bisacodyl
CAS:Produto Controlado<p>Impurity Bisacodyl EP Impurity A / SP Bisacodyl Related Compound A<br>Applications The active form of Bisacodyl. Cathartic.<br>References Roth, W., et al.: Arzneim.-Forsch. Drug Res., 38, 570 (1988), Bradshaw, K., et al.: J. Pharm. Biomed. Anal., 13, 1355 (1995), Wald, A., et al.: J. Clin. Gastroenterol., 36, 386 (2003),<br></p>Fórmula:C18H15NO2Cor e Forma:NeatPeso molecular:277.32Doxorubicin
CAS:<p>Doxorubicin (Adriamycin) is a Topoisomerase II (Top2) inhibitor with antineoplastic activity.</p>Fórmula:C27H29NO11Pureza:99.31%Cor e Forma:Red Crystalline Solid SolidPeso molecular:543.52Daunomycinone
CAS:<p>Applications Daunomycinone is the main metabolite of Daunorubicin (D194500).<br>References Hjelle, J.T., et al.: J. Pharmacol. Exp. Therap., 229, 372 (1984); Prikrylova, V., et al.: J. Antibiotics, 38, 1714 (1985)<br></p>Fórmula:C21H18O8Cor e Forma:RedPeso molecular:398.36Bisacodyl
CAS:Produto Controlado<p>Applications Cathartic.<br>References Schmidt, et al.: Arzneim.-Forsch., 3, 19 (1953), Wald, A., et al.: J. Clin. Gastroenterol., 36, 386 (2003),<br></p>Fórmula:C22H19NO4Cor e Forma:NeatPeso molecular:361.39Idarubicinol (Mixture of Diastereomers)
CAS:<p>Stability Hygroscopic<br>Applications Idarubicinol is the alcohol analog of Idrabucin (I167000), an orally active anthracycline; analog of Daunorubicin. Antineoplastic.<br>References Arcamone, F., et al.: Caner Treat. Rep., 60, 829 (1976), Zini, G., et al.: Cancer Chemother. Pharmacol., 16, 107 (1986), Gillies, H.C., et al.: Br.J. Clin. Pharmacol., 23, 303 (1987), Villani, F., et al.: Eur. J. Cancer Clin. Oncol., 25, 13 (1989),<br></p>Fórmula:C26H29NO9Cor e Forma:NeatPeso molecular:499.51N-(4-hydroxy-9,10-dioxo-9,10-dihydroanthracen-1-yl)acetamide
CAS:Pureza:98%Peso molecular:281.26699829101561,3,8-Trihydroxy-6-methyl-anthraquinone
CAS:Fórmula:C15H10O5Pureza:95%Cor e Forma:Solid, Red to orange powderPeso molecular:270.249,10-Dioxo-9,10-dihydro-anthracene-2,6-dicarboxylic acid
CAS:Pureza:97%Peso molecular:296.23400878906251-(Methylamino)anthracene-9,10-dione
CAS:Pureza:95.0%Cor e Forma:Solid, Reddish yellow - Deep yellow red powderPeso molecular:237.257995605468759,10-dioxo-9,10-dihydroanthracene-2-carbonyl chloride
CAS:Pureza:98.0%Peso molecular:270.67001342773441-(Methylamino)-4-(phenylamino)anthracene-9,10-dione
CAS:Pureza:95.0%Peso molecular:328.37100219726561,4-Bis((4-butylphenyl)amino)-5,8-dihydroxyanthracene-9,10-dione
CAS:Pureza:98%Peso molecular:534.656005859375Ref: 10-F801706
1gA consultar5gA consultar10mgA consultar25mgA consultar50mgA consultar100mgA consultar250mgA consultarBisoxatin
CAS:<p>Bisoxatin (LA 271A) is an oral laxative that can be used to study contact laxatives for chronic constipation.</p>Fórmula:C20H15NO4Pureza:99.47%Cor e Forma:SolidPeso molecular:333.34Daunorubicinol-13C,d3 (mixture of diastereomers)
CAS:Produto Controlado<p>Applications A metabolite of Daunorubicin. Used as an antineoplastic. Complexes with DNA. Inhibits DNA and RNA synthesis.<br>References Mizuno, N.S., et al.: Cancer Res., 35, 1542 (1975), Munger, C., et al.: Cancer Res., 48, 2404 (1988), Kobayashi, Y., et al.: J. Biol. Chem., 275, 17639 ( 2000), Burke, B., et al.: Cardiovasc. Toxicol., 2, 41 (2002),<br></p>Fórmula:CC26D3H28NO10Cor e Forma:NeatPeso molecular:533.55Sodium 1-amino-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate
CAS:Pureza:95%Peso molecular:325.26998901367191-amino-2-methylanthra-9,10-quinone
CAS:Pureza:98.0%Cor e Forma:Liquid, No data available.Peso molecular:237.25799560546875Daunomycinone
CAS:<p>Daunomycinone is a chemical compound that belongs to the group of antitumor agents. It is used in cancer therapy and has been shown to inhibit protein synthesis, leading to cell death. Daunomycinone can be synthesized by reacting adriamycin with trifluoroacetic acid in the presence of an organic base. This reaction produces a daunomycinone molecule that has a hydroxyl group at one end and a carbonyl group at the other. The binding constants between daunomycinone and human serum proteins have been determined experimentally using molecular modeling techniques. Hydrogen bonding interactions are also present in this complex, which may account for its high affinity for proteins found in human serum.</p>Fórmula:C21H18O8Pureza:Min. 95%Cor e Forma:Red PowderPeso molecular:398.36 g/molDoxorubicin impurity
CAS:<p>Doxorubicin is an organic compound that belongs to the class of polycyclic aromatic hydrocarbons. It is used as a cancer therapy, primarily in the treatment of breast cancer. The chemical sensing of impurities in doxorubicin can be done using phase transfer methods. The quantification of these impurities can be done using high-performance liquid chromatography (HPLC) or gas chromatography (GC).</p>Fórmula:C26H27NO11Pureza:Min. 90 Area-%Cor e Forma:Red PowderPeso molecular:529.49 g/molDaunorubicinol
CAS:<p>Daunorubicin metabolite</p>Fórmula:C27H31NO10Pureza:Min. 95%Cor e Forma:Red PowderPeso molecular:529.54 g/mol



